(Reuters) - A U.S. biotech company pioneering tablets containing embedded microchips that can tell if patients have taken their medication has raised a further $172 million, showing investor interest in its ingestible and wearable technology. [Category: healthNews] http://feeds.reuters.com/~r/reuters/healthNews/~3/HWheb4LsbDI/story01.htm
Read More
No comments:
Post a Comment